Novel insights into the assessment of risk of upper gastrointestinal bleeding in decompensated cirrhotic children.
Blood Coagulation
Child
Child, Preschool
End Stage Liver Disease
/ complications
Endoscopy
/ adverse effects
Esophageal and Gastric Varices
/ complications
Female
Fibrinogen
/ analysis
Gastrointestinal Hemorrhage
/ complications
Hemostasis
Humans
Hypertension, Portal
/ complications
Infant
Liver Cirrhosis
/ complications
Liver Transplantation
Male
Platelet Aggregation
Predictive Value of Tests
Prospective Studies
Risk Factors
Waiting Lists
chronic liver disease
esophageal varices
fibrinogen
hemostasis
platelet dysfunction
upper gastrointestinal bleeding
Journal
Pediatric transplantation
ISSN: 1399-3046
Titre abrégé: Pediatr Transplant
Pays: Denmark
ID NLM: 9802574
Informations de publication
Date de publication:
06 2019
06 2019
Historique:
received:
04
08
2018
revised:
16
01
2019
accepted:
10
02
2019
pubmed:
20
3
2019
medline:
22
4
2020
entrez:
20
3
2019
Statut:
ppublish
Résumé
Cirrhotic children wait-listed for liver transplant are prone to bleeding from gastrointestinal varices. Grade 2-3 esophageal varices, red signs, and gastric varices are well-known risk factors. However, the involvement of hemostatic factors remains controversial because of the rebalanced state of coagulation during cirrhosis. Children suffering from decompensated cirrhosis were prospectively included while being on waitlist. Portal hypertension was assessed by ultrasound and endoscopy. Coagulopathy was evaluated through conventional tests, thromboelastometry, and platelet function testing. The included children were followed up until liver transplantation, and all bleeding episodes were recorded. Children with or without bleeding were compared according to clinical, radiological, endoscopic, and biological parameters. In addition, validation of a predictive model for risk of variceal bleeding comprising of grade 2-3 esophageal varices, red spots, and fibrinogen level <150 mg/dL was applied on this cohort. Of 20 enrolled children, 6 had upper gastrointestinal bleeding. Significant differences were observed in fibrinogen level, adenosine diphosphate, and thrombin-dependent platelet aggregation. The model used to compute the upper gastrointestinal bleeding risk had an estimated predictive performance of 81.0%. Platelet aggregation analysis addition improved the estimated predictive performance up to 89.0%. We demonstrated an association between hemostatic factors and the upper gastrointestinal bleeding risk. A low fibrinogen level and platelet aggregation dysfunction may predict the risk of bleeding in children with decompensated cirrhosis. A predictive model is available to assess the upper gastrointestinal bleeding risk but needs further investigations. Clinicaltrials.gov number: NCT03244332.
Substances chimiques
Fibrinogen
9001-32-5
Banques de données
ClinicalTrials.gov
['NCT03244332']
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
e13390Informations de copyright
© 2019 Wiley Periodicals, Inc.